MIAMI, Feb. 1, 2005 (PRIMEZONE) -- Stock Market Alert's watch list includes: Southwestern Medical Solutions Incorporated (Pink Sheets:SWNM), Wyeth (NYSE:WYE), StemCells, Inc. (Nasdaq:STEM) and Atmel Corporation (Nasdaq:ATML).
Southwestern Medical Solutions, Inc. (Pink Sheets:SWNM) issued a press release that the company's design team has begun to advance the technical elements for a Carotid Endarterectomy Shunt. Before the news was released, the company's stock closed at twenty-four cents a share.
The press release stated that Carotid Endarterectomy is the surgery that removes harmful plaque from the carotid arteries. These arteries supply your brain with oxygen-laden blood; if plaque and other fatty materials block an artery, it stops the blood flow and the resultant lack of oxygen to the brain could cause a stroke.
As well, the company has developed manufacturing processes and new, patented, materials that will greatly enhance the development of all versions of its exclusively licensed Protect-A-Pal safety syringe products. Vice President of New Product Development, Richard Powell, noted, "These new patented, licensed materials, coupled with our latest designs, will allow us to construct a more maneuverable carotid shunt helping the surgeon to perform more precisely and potentially more efficiently."
Southwestern Medical is currently conducting research into various versions of its Carotid Shunts to determine which of those will be advanced toward manufacturing and product launch via the prototype -- clinical trials stages. The advancements in the available materials specifically licensed to Southwestern Medical are believed to give the company a leading edge in this surgical technique, which may help increase the effectiveness of the surgery by reducing both the incision size and the duration of the operation.
Southwestern Medical Has The Solution -- The Company's proprietary Labguard(tm) on-site collection & diagnostic testing technology represents a revolutionary approach that ensures greater safety and convenience for diagnostic testing administrators at an attractive, market-competitive price. Currently in the final prototype stage, Labguard(tm) has attracted expressions of strong interest from several major medical-device distribution companies, both in the U.S. and abroad. Numerous applications of the Labguard(tm) to address specific market needs, such as non-invasive HIV testing, are currently in the design, prototype and/or testing stages. Southwestern Medical is also involved in prototype design and testing of several versions of the promising Protect-A-Pal(tm) needle safety device, to which it now owns the world marketing rights.
Other stocks of interest yesterday were: Wyeth (NYSE:WYE) down 7.7% on 26.8 million shares traded, StemCells, Inc. (Nasdaq:STEM) up 0.6% on 7.9 million shares traded and Atmel Corporation (Nasdaq:ATML) up 0.9% on 10.4 million shares traded.
The release is provided by Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company received compensation for services performed for Southwestern Medical Solutions, Inc. (SWNM). The compensation is seventy four thousand dollars from non-affiliated third party, Alex Consulting Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.
The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment.
This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.